China NMPA Drug Inspection - Gansu Lanyao Pharmaceutical Co., Ltd. commissioned Gansu Fuzheng Pharmaceutical Technology Co., Ltd. - Zhenqi Fuzheng Capsules
China NMPA drug inspection for Gansu Lanyao Pharmaceutical Co., Ltd. commissioned Gansu Fuzheng Pharmaceutical Technology Co., Ltd. published February 09, 2021. Drug: Zhenqi Fuzheng Capsules. On February 9, 2021, the Beijing Municipal Drug Administration published its first drug quality and safety report for th
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA drug inspection for Gansu Lanyao Pharmaceutical Co., Ltd. commissioned Gansu Fuzheng Pharmaceutical Technology Co., Ltd. published February 09, 2021. Drug: Zhenqi Fuzheng Capsules. On February 9, 2021, the Beijing Municipal Drug Administration published its first drug quality and safety report for th
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox